Universe · entity
Commodore Capital LP
Institutional manager (13F) · CIK 1831942
13F holdings · as of 2026-03-31 · top 36 · reported portfolio $1.7B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | RELAY THERAPEUTICS INC | $169M | 17,000,000 |
| 2 | ALKERMES PLC | $149M | 4,200,000 |
| 3 | ENLIVEN THERAPEUTICS INC | $128M | 3,275,000 |
| 4 | COGENT BIOSCIENCES INC | $111M | 2,888,007 |
| 5 | SPYRE THERAPEUTICS INC | $96M | 1,912,380 |
| 6 | TYRA BIOSCIENCES INC | $95M | 2,475,000 |
| 7 | CELLDEX THERAPEUTICS INC NEW | $86M | 2,696,616 |
| 8 | NUVALENT INC | $85M | 833,600 |
| 9 | AMYLYX PHARMACEUTICALS INC | $79M | 5,650,000 |
| 10 | KYMERA THERAPEUTICS INC | $62M | 750,000 |
| 11 | ALTO NEUROSCIENCE INC | $61M | 2,723,196 |
| 12 | PHARVARIS N V | $54M | 1,918,970 |
| 13 | ERASCA INC | $51M | 3,175,000 |
| 14 | DAMORA THERAPEUTICS INC | $50M | 1,939,000 |
| 15 | XENON PHARMACEUTICALS INC | $48M | 825,000 |
| 16 | DEFINIUM THERAPEUTICS INC | $38M | 2,000,000 |
| 17 | LB PHARMACEUTICALS INC | $37M | 1,500,000 |
| 18 | EYEPOINT INC | $36M | 2,825,000 |
| 19 | NURIX THERAPEUTICS INC | $35M | 2,275,000 |
| 20 | CORVUS PHARMACEUTICALS INC | $33M | 2,258,735 |
| 21 | ASSEMBLY BIOSCIENCES INC | $28M | 1,000,000 |
| 22 | PERSPECTIVE THERAPEUTICS INC | $26M | 6,336,782 |
| 23 | SOLENO THERAPEUTICS INC | $22M | 652,432 |
| 24 | OCULAR THERAPEUTIX INC | $22M | 2,575,000 |
| 25 | CENTURY THERAPEUTICS INC | $20M | 8,695,652 |
| 26 | ZURA BIO LTD | $19M | 3,250,000 |
| 27 | SAB BIOTHERAPEUTICS INC | $17M | 4,401,500 |
| 28 | PALISADE BIO INC | $13M | 7,181,062 |
| 29 | KARYOPHARM THERAPEUTICS INC | $11M | 1,950,000 |
| 30 | INHIBIKASE THERAPEUTICS INC | $9M | 5,397,488 |
| 31 | AN2 THERAPEUTICS INC | $8M | 2,333,713 |
| 32 | PEPGEN INC | $8M | 4,475,000 |
| 33 | AVALO THERAPEUTICS INC | $7M | 483,000 |
| 34 | HELIX ACQUISITION CORP III | $5M | 500,000 |
| 35 | LEONABIO INC | $5M | 464,398 |
| 36 | RELMADA THERAPEUTICS INC | $4M | 633,901 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.